SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-19-004950
Filing Date
2019-04-19
Accepted
2019-04-19 17:12:31
Documents
3
Period of Report
2019-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp105320_8k.htm 8-K 17970
2 EXHIBIT 2.1 dp105320_ex0201.htm EX-2.1 699372
3 GRAPHIC image_001.jpg GRAPHIC 6415
  Complete submission text file 0000950103-19-004950.txt   727571
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 19758275
SIC: 2834 Pharmaceutical Preparations